NanoMed Europe 2025

NanoMed Europe: Celebrating Innovation and Milestones in Nanomedicine

NanoMed Europe, the flagship European conference dedicated to nanomedicine, returns with an extraordinary edition that goes beyond the ordinary. This year’s event marks a double anniversary: the celebration of both ETPN (European Technology Platform on Nanomedicine) and NanoMed Spain, two cornerstones in the development and promotion of nanomedicine across Europe.

Hosted in Spain, this edition of NanoMed Europe is not only a scientific gathering—it is a tribute to two decades of collaborative progress, groundbreaking discoveries, and visionary strategies that have shaped the field of nanomedicine in Europe. Researchers, clinicians, policymakers, and innovators will come together to honor achievements, reflect on challenges, and chart a bold new path for the future.
Nanomedicine: The Fusion of Science and Healing at the Nanoscale

Nanomedicine, a field where nanotechnology meets life sciences, continues to redefine diagnostics, targeted therapies, drug delivery, and regenerative medicine. It represents one of the most promising frontiers in healthcare, enabling treatment precision and personalization that were unthinkable a generation ago.

Key areas of nanomedicine explored at the conference include

• Nanodiagnostics and real-time imaging
• Targeted drug delivery systems for cancer and chronic diseases
• Nanotherapeutics and smart nanocarriers
• Nanobiosensors for point-of-care diagnostics
• Nanomaterials in tissue engineering and regenerative medicine
• Clinical translation of nano-enabled technologies

These focus areas highlight the vast scope of NanoMed Europe and its role in promoting cross-sector innovation, bridging academic research with industrial application and clinical adoption.

Why This Edition Is Unmissable: Two Milestones, One Vision

This year’s NanoMed Europe is a landmark occasion, marking the anniversaries of

ETPN (European Technology Platform on Nanomedicine): A European Commission initiative launched to coordinate and accelerate the development of nanomedicine in Europe. ETPN has been instrumental in shaping policy, funding, and strategic direction in the field.

NanoMed Spain: The national nanomedicine platform of Spain, which has played a crucial role in building a strong scientific and industrial ecosystem, supporting translational research, and fostering international collaborations.

This anniversary edition offers

Commemorative sessions on the history and impact of ETPN and NanoMed Spain.

Special keynote lectures from pioneers in nanomedicine and healthcare innovation.

Panel discussions reflecting on achievements and future priorities.

Networking receptions and celebratory events highlighting community spirit.

Showcase of collaborative European projects and funding opportunities.

This dual celebration enhances the sense of purpose and community, making NanoMed Europe 2025 an unforgettable experience for all attendees.

Who Should Attend NanoMed Europe?

NanoMed Europe gathers a vibrant, multidisciplinary audience that reflects the ecosystem required to bring nanomedicine from lab to bedside. From early-stage researchers to pharmaceutical executives, the conference is designed to engage all actors of the innovation chain.
Attendee profiles include:

• Biomedical and materials scientists
• Clinical researchers and physicians
• Nanotechnology engineers
• Pharmaceutical and biotech companies
• Regulatory and funding authorities
• Startups and venture capitalists
• National and European project coordinators
• IP and technology transfer specialists

The wide spectrum of participants ensures that science, industry, regulation, and investment converge to create meaningful and implementable outcomes.

A Conference Designed for Impact and Interaction

While NanoMed Europe is anchored in science, it is equally focused on creating actionable pathways to market. The program is rich in content, offering opportunities for learning, networking, and deal-making.

Highlights of the conference program

• Scientific sessions with high-impact research presentations
• Workshops on translational pathways and clinical trials
• Business and innovation forums connecting startups with investors
• Poster sessions showcasing emerging research from young scientists
• Interactive Q&A and roundtables for cross-disciplinary dialogue
• Project matchmaking opportunities for EU-funded initiatives

With its balance of academic rigor and practical application, the event remains a powerful accelerator of real-world progress in nanomedicine.

Supporting the Next Generation of Innovators

A core mission of NanoMed Europe is to empower early-career professionals. Young researchers and entrepreneurs are given a prominent platform to present, connect, and grow.

Special initiatives for young professionals include

• Best Poster and Presentation Awards
• Career development sessions
• Start-up pitch competitions
• One-on-one mentoring from senior leaders
• Travel grants and bursaries for eligible participants

By investing in the next generation, NanoMed Europe ensures continuity, sustainability, and the emergence of future leaders in the field.

Building a Stronger European Nanomedicine Ecosystem

Over the years, both ETPN and NanoMed Spain have been at the forefront of strengthening Europe’s position in global nanomedicine. This year’s conference serves as a reaffirmation of their shared vision: building an integrated ecosystem where innovation is supported from bench to market.

Strategic priorities discussed at the event will include

• Scaling clinical translation of nano-based therapies
• Enhancing cross-border collaboration through EU funding
• Strengthening regulatory frameworks and harmonization
• Promoting public-private partnerships
• Supporting SMEs and startups in deep-tech and nanotech fields

These themes position NanoMed Europe not just as a scientific gathering, but as a strategic engine for Europe's healthcare future.

A Celebration of Progress, and a Vision for Tomorrow

This special edition of NanoMed Europe is more than a conference—it is a celebration of vision, commitment, and collaborative success. As ETPN and NanoMed Spain mark major anniversaries, the event offers a rare opportunity to honor the past while boldly embracing the future.

In a world where precision medicine and advanced therapeutics are becoming the new standard, nanomedicine holds the promise of revolutionizing care at the cellular and molecular levels. NanoMed Europe 2025 stands at the heart of this transformation—uniting knowledge, experience, and ambition across disciplines and borders.

Whether you're an innovator, clinician, policymaker, or entrepreneur, NanoMed Europe is where the future of medicine begins—at the nanoscale.